{"filings":[{"id":90772,"accession_number":"0001654954-26-003746","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2026-04-20T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Aehr Test Systems fully utilizes ATM equity program, raises $60M gross proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Completed sales of common stock under at-the-market offering, aggregate gross proceeds of ~$60.0 million.","Shares sold pursuant to effective Form S-3 (File 333-282661) and prospectus supplement dated April 8, 2026.","ATM program previously announced; fully utilized as of April 17, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90771,"accession_number":"0001654954-26-003355","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2026-04-08T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"AEHR Test Systems enters $60M at-the-market equity distribution agreement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Up to $60M of common stock may be sold from time to time through agents William Blair and Craig-Hallum.","Shares sold via at-the-market offerings on Nasdaq or in negotiated transactions; 3% commission to agents.","Prospectus supplement filed April 8, 2026 under existing S-3 effective October 25, 2024.","Company not obligated to sell any shares; agents may suspend or terminate on written notice."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90770,"accession_number":"0001654954-26-003310","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2026-04-07T23:59:59+00:00","items":["2.02","5.03","9.01"],"status":"ready","headline":"Aehr Test Systems Q3 revenue $10.3M, bookings $37.2M; guides H2 at high-end of $60-80M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $10.3M vs $18.3M YoY; GAAP net loss $(3.2)M ($(0.10)/diluted) vs $(0.6)M loss ($(0.02)) YoY.","Non-GAAP net loss $(1.5)M ($(0.05)/diluted) vs non-GAAP income $2.0M ($0.07) YoY.","Quarterly bookings $37.2M; book-to-bill >3.5x; backlog $38.7M; effective backlog $50.9M.","Expects fiscal H2 (ends May 29, 2026) bookings at high end of $60-80M range, driven by AI hyperscaler PLBI orders.","Fiscal year end changed from May 31 to June 30 effective FY2027; transition period May 30-June 26, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":31166000.0,"consensus_period":"2026-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100560,"accession_number":"0001654954-26-000197","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2026-01-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Aehr Test Q2 FY2026: revenue $9.9M (-27% YoY), GAAP loss $(3.2)M, reinstates guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $9.9M, down 27% from $13.5M YoY; GAAP net loss $(3.2)M ($0.11/share) vs $(1.0)M loss ($0.03/share).","Non-GAAP net loss $(1.3)M ($0.04/share) vs non-GAAP net income $0.7M ($0.02/share) in prior-year quarter.","Bookings $6.2M; backlog $11.8M; effective backlog $18.3M; cash $31.0M, up from $24.7M sequentially.","First six months: revenue $20.9M (down 21% YoY), GAAP net loss $(5.3)M vs $(0.4)M loss YoY.","Reinstated fiscal 2026 guidance citing improved visibility for AI processor and data center test demand; specific figures not in this release."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":20853000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116888,"accession_number":"0001654954-25-012704","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2025-11-07T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Stockholders approve increases to share reserves under ESPP and 2023 Equity Plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["ESPP share reserve increased to 1,882,144 shares.","2023 Equity Incentive Plan overall share limit set at 4,000,000 shares plus prior plan awards.","Incentive Stock Option sub-limit under 2023 Plan set at 4,000,000 shares.","Amendments approved at October 20, 2025 annual meeting; effective October 21, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116887,"accession_number":"0001654954-25-012028","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2025-10-21T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Aehr shareholders approve equity plan increases and ratify auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six director nominees elected; votes for ranged from 11.95M to 12.79M; no change in board composition.","2023 Equity Incentive Plan share increase of 2.5M approved: 10.2M for, 2.6M against.","2006 ESPP share increase of 300K approved: 12.4M for, 408K against.","BPM LLP ratified as auditor for FY2026: 20.1M for, 40.5K against.","Say-on-pay passed (11.2M for, 1.6M against); 1-year frequency chosen for future votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116886,"accession_number":"0001654954-25-011494","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2025-10-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Aehr Test Systems Q1 revenue down 16% YoY to $11M; posts GAAP loss","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $11.0M, down from $13.1M in Q1 FY2025.","GAAP net loss $(2.1)M ($(0.07)/diluted share) vs net income $0.7M ($0.02) a year ago.","Non-GAAP net income $0.2M ($0.01/diluted share) vs $2.2M ($0.07) prior year.","Bookings $11.4M; backlog $15.5M, effective backlog $17.5M.","Cash and equivalents $24.7M vs $26.5M at end of May 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":10969000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133323,"accession_number":"0001654954-25-007859","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2025-07-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Aehr Test Systems Q4 revenue $14.1M, GAAP loss $(0.10)/share; full year revenue $59.0M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $14.1M in Q4 FY2025, down from $16.6M YoY; full year $59.0M vs $66.2M.","Q4 GAAP net loss $(2.9)M or $(0.10)/diluted share; prior year Q4 net income $23.9M ($0.81) incl $20.7M tax benefit.","Q4 non-GAAP net loss $(0.2)M or $(0.01)/diluted share; full year non-GAAP net income $4.6M ($0.15) vs $35.8M ($1.21).","Bookings $11.1M in Q4; backlog $15.2M at May 30, 2025; effective backlog $16.3M.","Cash and equivalents $26.5M at May 30, 2025, down from $31.4M at Feb 28, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":58968000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149979,"accession_number":"0001654954-25-004020","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2025-04-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Aehr Test Systems Q3 revenue up 141% to $18.3M, but withdraws guidance on tariff uncertainty","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $18.3M vs $7.6M YoY; GAAP EPS $(0.02) vs $(0.05) YoY.","Non-GAAP EPS $0.07 vs $(0.03) YoY; bookings $24.1M, backlog $18.2M.","Company temporarily withdraws fiscal 2025 guidance due to ongoing tariff uncertainty.","Cash and equivalents $31.4M vs $35.2M sequentially.","First nine months net revenue $44.9M vs $49.6M YoY; GAAP net loss $(1.0)M."],"consensus_eps_estimate":0.0,"consensus_eps_actual":-0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":44879000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169000,"accession_number":"0001654954-25-002152","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2025-02-28T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Aehr Test Systems adopts amended bylaws with advance notice provisions for stockholder meetings","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board approved amended and restated bylaws on Feb 24, 2025, effective immediately.","Adds advance notice requirements for director nominations and other stockholder proposals.","Includes administrative, modernizing, clarifying, and conforming changes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168999,"accession_number":"0001654954-25-000292","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2025-01-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Aehr Test Systems Q2 revenue falls to $13.5M; GAAP net loss $0.03/share; reaffirms FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $13.5M, down from $21.4M in Q2 FY2024 (-37% YoY).","GAAP net loss of $(1.0)M ($0.03 diluted loss); Non-GAAP net income $0.7M ($0.02 diluted).","Bookings of $9.2M; effective backlog $26.6M as of January 13, 2025.","Cash and restricted cash $35.2M, down from $40.8M at August 30, 2024.","Company reiterates full-year fiscal 2025 financial guidance."],"consensus_eps_estimate":-0.0153,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":26572000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186080,"accession_number":"0001654954-24-013223","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2024-10-22T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Aehr Test Systems shareholders elect all directors, ratify auditor, approve say-on-pay at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six nominees elected: Rhea J. Posedel, Gayn Erickson, Fariba Danesh, Laura Oliphant, Geoffrey G. Scott, Howard T. Slayen.","Ratification of BPM LLP as independent auditor for FY2025 passed with 19,862,906 votes for, 137,816 against, 59,280 abstain.","Advisory vote on named executive officer compensation approved with 12,837,526 for, 339,095 against, 163,624 abstain, 6,719,757 broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186079,"accession_number":"0001654954-24-012870","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2024-10-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Aehr Test Systems Q1 revenue $13.1M, down 36% YoY; GAAP EPS $0.02 vs $0.16","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $13.1M (down 36% YoY from $20.6M); GAAP net income $0.7M ($0.02 EPS) vs $4.7M ($0.16).","Non-GAAP net income $2.2M ($0.07 diluted) vs $5.2M ($0.18) in prior year.","Bookings $16.8M, backlog $16.6M as of Aug 30, 2024.","Cash $40.8M (down from $49.3M) due to $10.6M acquisition of Incal Technology.","Reaffirms full-year fiscal 2025 guidance; no specific numbers in release."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":13119000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202696,"accession_number":"0001654954-24-011548","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2024-09-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Aehr Test Systems enters new severance agreements with CEO, CFO, and other executives","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Gayn Erickson: 24 months salary, 200% target bonus, full equity acceleration on change-in-control termination.","CFO Chris P. Siu: 18 months salary, 150% target bonus; other execs: 12 months salary, 100% target bonus.","Outside change in control: CEO 12 months, CFO 9 months, other execs 6 months salary, with prorated bonus and partial equity vesting.","Death or disability triggers non-CIC severance with healthcare continuation; disability includes ArmadaCare benefit.","Agreements effective August 31, 2024, superseding prior severance agreements for all named officers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202695,"accession_number":"0001654954-24-009808","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.01","1.01"],"status":"ready","headline":"Aehr Test Systems completes acquisition of Incal Technology for $21M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total purchase price $21.0M: $14.0M cash + $7.0M in Aehr common stock.","Issued 552,355 shares at $12.673 per share as stock consideration.","Acquisition closed July 31, 2024, per previously announced Stock Purchase Agreement.","Purchase price subject to post-closing working capital adjustments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202694,"accession_number":"0001654954-24-009013","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2024-07-16T23:59:59+00:00","items":["2.02","5.03","9.01"],"status":"ready","headline":"Aehr Test Systems Reports Fiscal Q4 2024 Revenue $16.6M, Full Year Record Revenue $66.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue for Q4 fiscal 2024 was $16.6 million, down from $22.3 million in Q4 fiscal 2023.","GAAP net income for Q4 was $23.9 million ($0.81 per diluted share), including a $20.8 million tax benefit from valuation allowance release.","Full year fiscal 2024 net revenue reached a record $66.2 million, up from $65.0 million in fiscal 2023.","Board approved change in fiscal year end to a 4-4-5 calendar ending on the Friday closest to May 31, effective June 1, 2024.","Non-GAAP net income for Q4 was $24.7 million ($0.84 per diluted share), compared to $6.8 million in prior year quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":1.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":66218000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202693,"accession_number":"0001654954-24-009008","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2024-07-16T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"Aehr Test Systems acquires Incal Technology for $21M to bolster AI semiconductor test market","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price: $14M cash + 552,355 shares of Aehr common stock valued at $7M ($12.673/share).","Incal's trailing 12-month revenue ~$12M from burn-in systems and consumables for AI/GPU/HPC devices.","Acquisition expected to be immediately accretive; close targeted within 60 days subject to conditions.","Deal adds ultra-high-power burn-in capabilities for AI accelerators drawing 1,000W+, expanding Aehr's portfolio.","Incal brings relationships with leading AI semiconductor manufacturers and their subcontractors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202692,"accession_number":"0001654954-24-008746","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2024-07-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Aehr Test Systems Q4 revenue ~$16.6M, FY revenue ~$66.2M, beats guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP net income ~$23.8M includes $20.8M tax benefit from releasing valuation allowance.","Full-year GAAP net income ~$33.1M; revenue of $66.2M exceeded guidance of at least $65M.","CEO cites record annual revenue despite SiC pushouts from slowing EV demand in H2.","FY2025 outlook expects broader market traction in silicon photonics, GaN, and AI processors.","Preliminary results ahead of July 16 earnings call; analyst consensus was surpassed."],"consensus_eps_estimate":null,"consensus_eps_actual":1.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":66218000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218851,"accession_number":"0001654954-24-006995","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2024-05-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Aehr Test Systems posts updated May 2024 corporate presentation; no material new information disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company posted an updated corporate presentation on its website on May 29, 2024.","Presentation is accessible via the Investor Relations section of aehr.com.","No specific financial or operational updates were provided in the filing or exhibit.","Presentation is summary information; Company undertakes no duty to update."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218850,"accession_number":"0001654954-24-004414","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2024-04-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Aehr Q3 revenue $7.6M, GAAP loss $0.05/sh; reiterates FY24 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $7.6M, down 56% YoY from $17.2M in Q3 FY23.","GAAP net loss $1.5M ($0.05 diluted loss) vs net income $4.1M ($0.14) YoY.","Non-GAAP net loss $0.9M ($0.03) vs non-GAAP income $4.7M ($0.16) YoY.","Bookings $24.5M, backlog $20M at Feb 29, 2024; cash $47.6M.","Reiterates full-year fiscal 2024 financial guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":0.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":49618000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238756,"accession_number":"0001654954-24-000428","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2024-01-10T23:59:59+00:00","items":["1.02"],"status":"ready","headline":"Aehr Test Systems terminates Loan Agreement with Silicon Valley Bank; no outstanding balance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Loan and Security Agreement with Silicon Valley Bank terminated effective January 4, 2024.","No amounts were outstanding under the facility as of termination date.","Lender's security interest in company assets and property released.","Certain indemnification obligations survive termination per customary terms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238755,"accession_number":"0001654954-24-000372","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2024-01-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Aehr Test Systems Q2 revenue up 45% YoY to $21.4M, guides FY2024 rev $75-85M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 GAAP net income $6.1M ($0.20 diluted EPS), up 63% YoY from $3.7M ($0.13).","Q2 Non-GAAP net income $6.7M ($0.23 diluted EPS), up 49% YoY from $4.5M ($0.16).","First-half FY2024 revenue $42.1M, up 65% YoY; GAAP net income $10.8M ($0.36 EPS), up 149%.","Revised full-year guidance: revenue $75M-$85M, GAAP net margin 20%-25% of revenue.","Cash and equivalents $50.5M at Nov 30, 2023, vs $51.0M at Aug 31, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":0.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":42055000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":256243,"accession_number":"0001654954-23-013387","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2023-10-25T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Aehr Test Systems annual meeting results: all four proposals passed, including 2023 equity plan (1.5M shares)","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Six directors re-elected; Rhea Posedel received 9,001,500 for, 5,779,054 withheld; others had higher tallies.","2023 Equity Incentive Plan approved (12,542,957 for, 996,473 against, 1,241,124 abstain, 6,177,835 broker non-votes).","BPM LLP ratified as independent auditor for FY2024 (20,882,701 for, 51,499 against, 24,189 abstain).","Advisory vote on executive compensation approved (13,520,292 for, 1,172,122 against, 88,140 abstain, 6,177,835 broker non-votes)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":256242,"accession_number":"0001654954-23-012655","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2023-10-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Aehr Test Systems Q1 FY2024 revenue $20.6M, up 93% YoY; GAAP EPS $0.16 vs $0.02","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $20.6M (+93% YoY); GAAP net income $4.7M ($0.16 diluted EPS).","Non-GAAP net income $5.2M ($0.18 diluted) vs $1.3M ($0.05) a year ago.","Bookings $18.4M for the quarter; backlog $22.3M as of Aug 31, 2023.","Cash from operations $3.9M; total cash $51.0M, up from $47.9M at May 31.","Strength in production wafer level burn-in products for silicon carbide semiconductors."],"consensus_eps_estimate":null,"consensus_eps_actual":0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":20624000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":273652,"accession_number":"0001654954-23-009282","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2023-07-17T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Aehr Test Systems sets FY2024 executive comp; CTO Hendrickson retired May 31","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Erickson base salary $456k; annual equity award 25,239 RSUs plus performance shares up to 45,078 total.","EVP Rogers base salary $283,500; annual equity award 6,200 RSUs plus performance shares up to 13,408 total.","CTO Hendrickson retired as officer effective May 31, 2023; no replacement named.","Board eliminated per-meeting fees; Chairman gets $87.5k cash + $160k RSUs; other chairs $72.5k cash + $140k RSUs.","CEO eligible for target cash bonus up to 106.4% of base tied to profitability, bookings, new customers, ESG."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":273651,"accession_number":"0001654954-23-009130","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2023-07-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Aehr Test Systems reports record FY2023 revenue $65M, EPS $0.50; guides >50% revenue growth in FY2024","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $22.3M (record), GAAP EPS $0.21, non-GAAP EPS $0.23.","FY23 revenue $65.0M (record, +28% YoY), GAAP EPS $0.50 (+54% YoY), non-GAAP EPS $0.59.","Effective backlog $39.7M including post-quarter orders; cash $47.9M.","Guides FY2024 revenue >50% over FY2023 on wafer-level test and burn-in demand."],"consensus_eps_estimate":null,"consensus_eps_actual":0.5,"consensus_revenue_estimate":null,"consensus_revenue_actual":64961000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":290658,"accession_number":"0001654954-23-007424","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2023-05-31T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Aehr Test Systems appoints Chris Siu as CFO effective June 1, 2023; Ken Spink retiring","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Chris Siu becomes EVP of Finance, CFO, and Secretary, effective June 1, 2023.","Annual base salary of $336,000; target cash bonus of 75% of base; initial equity grant of $600,000 vesting over four years.","Siu brings 27+ years of semiconductor and public accounting experience, previously SVP Finance at Ultra Clean Technologies.","Ken Spink will remain through August 31, 2023, to assist transition after 15 years with the company.","New CFO also receives change-of-control severance: 12 months base pay, prorated bonuses, full equity vesting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":290657,"accession_number":"0001654954-23-007423","cik":1040470,"company_name":"AEHR TEST SYSTEMS","ticker":"AEHR","form_type":"8-K","filed_at":"2023-05-31T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Aehr Test Systems CTO David Hendrickson retires; no replacement planned","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["David S. Hendrickson retired as Chief Technology Officer effective May 31, 2023.","Company currently has no plans to replace the CTO position.","Hendrickson served over 20 years; CEO Gayn Erickson thanked him for leadership."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3265476848.527838,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}